Gene · 2621
NIH grants2,018
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,301 to 1,320 of 2,018
Download this page as JSON| Grant | Title | GAS6 papers | Newest fiscal year |
|---|---|---|---|
| R01MH104680 | Integration of brain imaging with genomic and epigenomic data | 1 | 2017 |
| R01NS081740 | Neurovascular Protection for Early Brain Injury after SAH | 1 | 2017 |
| R01NS083767 | Targeting MELK-mediated EZH2 signaling in glioma stem cells | 1 | 2017 |
| R01NS084912 | Modulating Autophagy to Eradicate HIV-1 from CNS Reservoirs | 1 | 2017 |
| R03ES027394 | Translational mixed-factor benchmark-dose risk assessment | 1 | 2017 |
| R21AI126219 | MADS-box transcriptional regulation of dimorphic transition in Penicillium marneffei | 1 | 2017 |
| R21CA201865 | Using DNA methylation markers to improve the predictive accuracy and utility of needle biopsiesfor determining prostate cancer aggressiveness | 1 | 2017 |
| R21CA202403 | Augmented homologous recombination as a mechanism of acquired temozolomide resistance in glioblastoma | 1 | 2017 |
| R21CA205936 | SIRT5 as a Therapeutic Target in Acute Myeloid Leukemia | 1 | 2017 |
| R21EY027065 | A disease-specific retinal angiogenic factor and its receptor | 1 | 2017 |
| R21HD086820 | Deconstructing the cellular basis of thalamic nuclei specification by in vivo clonal analysis | 1 | 2017 |
| R21HD091163 | Nonhuman Primate Model to Assess Embryonic Zika Virus Infection | 1 | 2017 |
| R21MH110160 | Deconstructing the hypothalmic ontogeny and plasticity via clonal analysis | 1 | 2017 |
| R24EY022883 | Novel Antiangiogenic Peptides for Treatment of Exudative AMD | 1 | 2017 |
| R24HS022418 | UT Southwestern Center of Patient-Centered Outcomes Research (PCOR) | 1 | 2017 |
| R37DK026263 | Red Cell Deformability InVitro and Survival InVivo | 1 | 2017 |
| R41EY027665 | Developing a novel therapy for diabetic retinopathy | 1 | 2017 |
| R56AG057469 | Biogenesis of Exosomes, Secretion, and Trafficking in Alzheimer's Disease | 1 | 2017 |
| R56AI132515 | Causes and implications of differential AXL use by ZIKV and WNV | 1 | 2017 |
| R56HL135124 | Differential role of tissue-resident and monocyte-derived alveolar macrophages in the development of pulmonary fibrosis | 1 | 2017 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/grants?page=66